Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Na+/K+-ATPase inhibitors revealed by Sigma-Tau

July 12, 1996

M2 antagonists reported by Yamanouchi

July 5, 1996

Kyowa Hakko's OXT displays cardiotonic and insulin release-promoting effects

July 5, 1996

NEP inhibitors claimed by Santen

July 5, 1996

AHP describes tricyclic benzazepine vasopressin antagonists

July 5, 1996

Alexion begins phase I testing of 5G1.1-SC

July 5, 1996

TMR with PLC Systems' Heart Laser continues to display efficacy

July 5, 1996

First launch for Ciba-Geigy angiotensin II antagonist

July 5, 1996

Warner-Lambert reports nonpeptide ET antagonists

July 5, 1996

Norvasc labeling revised by FDA

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...